This is a PDF-only article. The first page of the PDF of this article appears above.
In this issue
Jump to section
Related Articles
Cited By...
- Principles of Tracer Kinetic Analysis in Oncology, Part I: Principles and Overview of Methodology
- [18F]-3'Deoxy-3'-Fluorothymidine Positron Emission Tomography and Breast Cancer Response to Docetaxel
- Developmental Changes in P-Glycoprotein Function in the Blood-Brain Barrier of Nonhuman Primates: PET Study with R-11C-Verapamil and 11C-Oseltamivir
- Reproducibility of [11C]Choline-Positron Emission Tomography and Effect of Trastuzumab
- [11C]Choline Positron Emission Tomography in Estrogen Receptor-Positive Breast Cancer
- Phase I Trial of the Positron-Emitting Arg-Gly-Asp (RGD) Peptide Radioligand 18F-AH111585 in Breast Cancer Patients
- Kinetic Analysis of 3'-Deoxy-3'-18F-Fluorothymidine in Patients with Gliomas
- Quantification of Cellular Proliferation in Tumor and Normal Tissues of Patients with Breast Cancer by [18F]Fluorothymidine-Positron Emission Tomography Imaging: Evaluation of Analytical Methods
- Kinetic Analysis of 3'-Deoxy-3'-Fluorothymidine PET Studies: Validation Studies in Patients with Lung Cancer
- 2-[C-11]Thymidine Imaging of Malignant Brain Tumors